Efficacy of the implantable cardioverter-defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy

被引：0

作者：

Maron, BJ

Shen, WK

Link, MS

Epstein, AE

Almquist, AK

Daubert, JP

Bardy, GH

Rea, RF

Favale, S

Boriani, G

Estes, NAM

Spirito, P

机构：

[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA

[2] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

[3] Tufts Univ, New England Med Ctr, Sch Med, Boston, MA 02111 USA

[4] Univ Alabama, Birmingham, AL USA

[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

[6] Univ Washington, Med Ctr, Seattle, WA 98195 USA

[7] Univ Bologna, Bologna, Italy

[8] Univ Bari, Bari, Italy

[9] Osped Galliera, Genoa, Italy

来源：

CIRCULATION | 1999年 / 100卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3383

引用

页码：642 / 642

页数：1

共 50 条

[21] Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy
Cordeiro de Paula, Leonardo Jorge
Ribeiro, Henrique Barbosa
de Oliveira Junior, Roberto Marcio
da Silva, Katia Regina
REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2010, 25 (03): : 406 - 409
[22] Efficacy of implantable cardioverter-defibfillators for sudden cardiac death prevention in hypertrophic cardiomyopathy
Malecka, L
Przybylski, A
Sterlinski, M
Chojnowska, L
Szwed, H
Ruzyllo, W
EUROPEAN HEART JOURNAL, 2004, 25 : 542 - 542
[23] Efficacy and safety of celivarone,with amiodarone as calibrator,in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death
South China Journal of Cardiology, 2012, (01) : 56 - 56
[24] Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
Sarrias, Axel
Galve, Enrique
Sabate, Xavier
Moya, Angel
Anguera, Ignacio
Nunez, Elaine
Villuendas, Roger
Alcalde, Oscar
Garcia-Dorado, David
REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (06): : 492 - 496
[25] Sudden death as a presenting symptom of hypertrophic cardiomyopathy: Treatment with an implantable cardioverter defibrillator
Talard, P
Levy, S
Bonal, J
Paganelli, F
Bouchiat, C
Cellarier, G
Dussarat, GV
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (08): : 1264 - 1267
[26] Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy
Cardinalli-Neto, Augusto
Nakazone, Marcelo A.
Grassi, Luciano V.
Tavares, Bruno G.
Bestetti, Reinaldo B.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 94 - 95
[27] Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with Arrhythmogenic right ventricular cardiomyopathy/dysplasia
Corrado, D
Leoni, L
Link, MS
Della Bella, P
Gaita, F
Curnis, A
Salerno, JU
Igidbashian, D
Raviele, A
Disertori, M
Zanotto, G
Verlato, R
Vergara, G
Delise, P
Turrini, P
Basso, C
Naccarella, F
Maddalena, F
Estes, NAM
Buja, G
Thiene, G
CIRCULATION, 2003, 108 (25) : 3084 - 3091
[28] Is one major risk factor for sudden death enough to indicate an Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy?
Landeta, F.
Fernandez, A.
Gonzalez, J. L.
Casabe, J. H.
Guevara, E.
Medesani, L.
Galizio, N.
EUROPEAN HEART JOURNAL, 2009, 30 : 419 - 419
[29] Implantable cardioverter defibrillators for primary prevention of sudden death in hypertrophic cardiomyopathy
Konstantinou, Dimitrios M.
Efthimiadis, Georgios K.
Vassilikos, Vassilios
Paraskevaidis, Stylianos
Pagourelias, Efstathios
Maron, Barry J.
Karvounis, Haralambos
JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (06) : 433 - 439
[30] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR PREVENTION OF SUDDEN CARDIAC DEATH IN CHILDREN AND ADOLESCENTS
PAUL, T
LUHMER, I
TRAPPE, HJ
KLEIN, H
FIEGUTH, HG
BRAUER, C
SCHARPWINKEL, U
KALLFELZ, HC
ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 (08): : 466 - 473

← 1 2 3 4 5 →